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Edited by Gunnar von Heijne and Anders LiljasAbstract Members of the Y-family of DNA polymerases cata-
lyze template-dependent DNA synthesis but share no sequence
homology with other known DNA polymerases. Y-family
polymerases exhibit high error rates and low processivity when
copying normal DNA but are able to synthesize DNA opposite
damaged templates. In the past three years, much has been
learned about this family of polymerases including determination
of more than a dozen crystal structures with various substrates.
In this short review, I will summarize the biochemical properties
and structural features of Y-family DNA polymerases.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The eﬀects of Y-family polymerases were ﬁrst noted over 30
years ago. It was observed that DNA damage-induced repair
was often accompanied by a high frequency of mutations, a
process known as SOS repair and mutagenesis [1]. By the early
1980s, the SOS responsive genes essential for the mutagenesis
were identiﬁed in Escherichia coli (UmuCD, Umu stands for
UV-induced mutagenesis) and yeast (Rev1, Rev3 and Rev7)
[2,3]. UmuCD 0 and Rev1 proteins contained no recognizable
sequence motifs, however, and resisted overproduction and
characterization. The phenomenon of DNA damage-induced
mutagenesis was thus thought to result from modiﬁcation of
replicative DNA polymerases, which were somehow trans-
formed to bypass damaged template but synthesized DNA
with lower ﬁdelity as a side eﬀect [4]. The myth of ‘‘modifying’’
proteins was challenged in 1996 when the yeast Rev1 protein
was shown to possess a dCMP-speciﬁc nucleotidyl transferase
activity [5]. By 1999, both E. coli homologs of Rev1, UmuC
(complexed with UmuD 0) and DinB (Damage induced) were
shown to possess DNA polymerase activity and carry out tran-
slesion DNA synthesis [6–8]. The excitement of these discover-
ies was compounded by the isolation of human DNA
polymerase g (Polg), a homolog of Rev1, UmuC and DinB
that is encoded by XPV [9,10]. Mutations of the XPV gene
cause xeroderma pigmentosum (XP), a disease marked by ex-*Fax: +1 301 496 0201.
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cers. The shared enzymatic properties and amino-acid
sequence motifs of Rev1, UmuC, DinB and Polg deﬁne a
new family of DNA polymerases, named Y following the rep-
licative A, B, C and D families and repair X family [11].
Y polymerases are widespread. In E. coli, two out of a total
of ﬁve DNA polymerases belong to the Y-family, PolIV
(DinB) and PolV (UmuCD 0). Homologs of UmuC and DinB
exist in virtually all eubacteria, and DinB homologs are found
even in some archaea [12]. In humans, there are at least four
Y-family polymerases, Polg, i, j and Rev1 [13,14]. Polg and
Rev1 are found in every eukaryote that has been examined.
Expression of Y-family polymerases is limited under normal
growth conditions and is induced in the presence of DNA-
damaging agents. The main functions of Y polymerases are
to rescue-stalled replication forks and enhance cell survival
upon DNA damage [15].
All Y polymerases share ﬁve conserved sequence motifs with-
in the N-terminal 350 residues, but their overall length and the
C-terminus vary considerably. Eukaryotic homologs are often
twice as large as archaeal and bacterial counterparts. The C-ter-
minal half often contains sequence motifs for nuclear localiza-
tion [16] and for interaction with replication processivity
factor (b sliding clamp and PCNA) [17–19] or other polyme-
rases [20,21]. Y-family polymerases lack a 3 0 ﬁ 5 0 exonuclease
activity, which is an integral part of all replicative polymerases
and performs a proofreading function. Interestingly, each Y-
family polymerase diﬀers in substrate speciﬁcity, that is, the
type of lesions bypassed and mutation spectra generated.
Crystal structures of archaeal Dbh [22,23] and Dpo4 [24], the
N-terminal catalytic domain of Polg (Saccharomyces cerevisiae)
[25], Poli (human) and Polj (human) [26,27] have been reported.
Although bothDpo4 and Poli have been crystallized in complex
with DNA substrates, the Poli crystals appeared to be partially
disordered [26], and the reported structure contains a large num-
ber of stereochemical abnormalities (PDB: 1T3N). This review
therefore will focus onDpo4, crystal structures of which include
complexes with normal DNA, abasic lesions, a thymine dimer,
and a benzo[a]pyrene adduct. The Dpo4 structures will also be
compared with the Dbh, Polg, i and j structures.2. An open and solvent accessible active site
All crystal structures of Y-family polymerases reported to
date consist of ﬁnger, thumb and palm domains arranged in
a classic ‘‘right hand-like’’ conﬁguration (Fig. 1A). The Yblished by Elsevier B.V. All rights reserved.
Fig. 1. The crystal structure ofDpo4 complexedwith normalDNA. (A)
Dpo4 is shown in molecular surface, and the palm (red), ﬁnger (blue),
thumb (green) and little ﬁnger (purple) domains are color-coded. The
template and primer strand are shown as brown and yellow sticks, and
the incoming nucleotide is in silver. (B) Comparison of the interface
between a replicating base pair (green) and A, B, and Y polymerases
(pink). The interface in a high ﬁdelity polymerase (A and B family) is
entirely complementary (left, PDB: 1IG9), but in Dpo4 it is imperfect
and has space to accommodate a wobble base pair (right, PDB: 1JX4).
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rather small ﬁnger and thumb domains, which leads to an open
and solvent accessible active site in the palm domain. Dpo4
interacts mainly with the DNA backbone and the sugar-phos-
phate moiety of an incoming deoxynucleotide. There is little
contact between the Dpo4 active site and the replicating base
pair or preceding DNA duplex either in the major or minor
groove, where a perfect or mismatched base pair may be distin-
guished. Watson–Crick base pairs always have a ﬂat and
smooth minor groove with a similar pattern of potential
hydrogen bonds, but the minor groove of mismatched base
pairs is uneven and presents varied patterns of hydrogen-bond
donors and acceptors. The lack of an intimate and comple-
mentary interface between a polymerase and replicating base
pair provides a structural foundation for the high-error-rate
and low-ﬁdelity DNA synthesis (Fig. 1B).
The high ﬁdelity of replicative DNA polymerases also de-
pends on an ‘‘induced-ﬁt’’ conformational change to discrimi-nate against a wrong incoming nucleotide. A correct incoming
deoxynucleoside triphosphate makes a Watson–Crick base
pair with the templating base and induces structural rearrange-
ment of the ﬁnger domain, which secludes the replicating base
pair in a closed active site [28]. An incorrect incoming nucleo-
tide or damaged template base hinders this conformational
change and reduces the rate of polymerization. In contrast to
such an induced-ﬁt’’ screening of incoming nucleotides, the ac-
tive site of Dpo4 is preformed regardless of whether an incom-
ing nucleotide is incorrect or the template base is damaged or
even absent. Dpo4 is committed and always ready to catalyze
the nucleotidyl transfer reaction. A preformed active site is
also observed with Dbh, Poli and j.3. A ﬂexible little ﬁnger enhances the catalytic eﬃciency
Conformational changes do occur in Y polymerases upon
association with substrate, but these changes occur primarily
outside of the active site. All Y-family polymerases have a un-
ique C-terminal domain in addition to the catalytic core of ﬁn-
ger, thumb and palm domains (Fig. 1A). This extra domain
has been called little ﬁnger and plays a role in holding the
DNA duplex opposite the thumb domain. It has also been re-
ferred to as the polymerase-associated domain (PAD) or wrist
domain [23,25]. The little ﬁnger domain appears to be the most
mobile region in Dbh, Dpo4, Polg and j. It is localized only
upon tight association with a DNA duplex.
The little ﬁnger domains were swapped between two archa-
eal DinB homologs, Dbh and Dpo4, which share 50% se-
quence identity but have drastically diﬀerent catalytic
eﬃciencies and mutation spectra. We ﬁnd that the little ﬁnger
domain determines the catalytic eﬃciency and mutation spec-
tra of each polymerase by inﬂuencing enzyme–substrate inter-
actions [29]. Weak association of the polymerase and DNA
substrate reduces the nucleotidyl transferase activity of the en-
zyme and increases frame-shift mutation by DNA misaligning.4. Looping out of abasic lesions
It is estimated that in a mammalian cell, 9000 bases are
spontaneously lost each day [30]. Although most abasic lesions
are removed by base-excision repair prior to DNA synthesis, a
small number of lesions may escape from repair or occur dur-
ing S phase and pose a serious challenge to DNA replication.
Abasic lesions prevent the conformational changes in the ﬁn-
ger domain and block DNA synthesis by replicative polyme-
rases [31,32]. DinB and its homologs (Dbh and Dpo4),
however, are particularly eﬃcient at bypassing abasic lesions.
A set of three crystal structures of Dpo4 inserting deoxynu-
cleotide or extending a primer opposite an abasic lesion have
been determined [33]. Dpo4 loops out the abasic lesion and
uses the base 5 0 to the lesion to direct nucleotide incorporation.
The looped out DNA backbone is accommodated in the gap
between the ﬁnger and little ﬁnger domain (Fig. 2A). After
bypassing the abasic lesion, the polymerase extends the primer
in two alternative ways. It may keep the abasic lesion looped
out and proceed with DNA synthesis resulting in a 1 frame-
shift (Fig. 2B). Alternatively, Dpo4 may realign the template
so that the abasic lesion is opposite the newly incorporated
Fig. 2. Crystal structures of Dpo4 complexed with abasic lesions. Dpo4
is shown as gray surface; the template strand (yellow) with an abasic
analog (tetrahydrofuran, red), primer strand (blue), and an incoming
nucleotide (purple) are shown in stick models. The green spheres
represent the divalent metal ions in the active site. (A) The abasic lesion
is looped out when placed opposite an incoming nucleotide (PDB:
1S0N). (B) and (C) Primer extension past the abasic site. The abasic
lesion can remain looped out (PDB: 1S0O) (B) or become intra-helical
and opposite the 3 0 end of the primer strand (PDB: 1S10) (C).
Fig. 3. Crystal structures of Dpo4 complexed with a cis–syn thymine
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rects the nucleotide incorporation (Fig. 2C). In fact, deletion
mutations are frequently observed both in vitro and in vivo
when abasic lesions are bypassed by DinB-like Y-family
polymerases [34–36].dimer (CPD). (A) A close-up view of ddATP incorporation opposite
the 3 0 thymine of CPD by Dpo4 (PDB: 1RYR). Presentation and the
color scheme are similar to Fig. 2 except for the red-and-pink CPD and
multi-colored ddATP. (B) The 3 0 thymine of CPD forms a Watson–
Crick base pair with the incoming ddATP, while the 5 0 thymine forms
a Hoogsteen base pair (PDB: 1RYS). The thymine of CPD that is base
paired with ddATP is shown in red and the other thymine in pink.5. Hoogsteen base pair with thymine dimer
Cyclobutane pyrimidine dimers (CPDs) are the major
photoproducts of UV irradiation and are removed by nucleo-tide excision repair in species ranging from E. coli to human.
Xeroderma pigmentosum may result from failures of either
DNA repair (80%) or translesion synthesis by Polg (20%)
[37]. The most extensively studied CPDs, cis–syn thymine di-
mers, consist of two adjacent thymine bases covalently linked
between C5–C5 and C6–C6. Replicative polymerases accom-
modate one template base in the active site at a time and reject
thymine dimers outright [38].
We have determined crystal structures of Dpo4 inserting
ddATP opposite either the 3 0 or 5 0 thymine of a cis–syn thy-
mine dimer [39]. When the 3 0 thymine serves as the template
base, the entire CPD is accommodated by the open active site
of Dpo4 (Fig. 3A). The incoming ddATP makes normal
hydrogen bonds with the thymine (Fig. 3B). When the 5 0 thy-
mine is the templating base, the polymerase ﬂips the incoming
dATP to a syn conformation (Fig. 3B). This enables ddATP to
form a Hoogsteen base pair with the under-twisted and highly
buckled 5 0 thymine and maintain the triphosphate moiety in
the active site for the nucleotidyl transfer reaction to take
place. Only ddATP can base pair with thymine in the syn con-
formation, which leads to the higher ﬁdelity of nucleotide
incorporation by Y polymerases opposite the 5 0 thymine than
the 3 0 thymine of CPDs.
Dpo4, however, is not as eﬃcient as Polg in bypassing
CPDs. Comparison of the Dpo4–thymine dimer complex
and Polg apoprotein structures suggests that the active site
of Polg may be more ﬂexible and less solvent exposed [39].
A crystal structure of a Polg–CPD complex will be essential
for us to fully understand its substrate selectivity.
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Benzo[a]pyrene (BP), a poly-aromatic hydrocarbon com-
pound, is found in burnt coal, petroleum and tobacco, and
even natural foods. In mammals, BP is metabolized to benzo[a
]pyrene diol epoxide (BPDE), which is highly reactive and
forms covalent bonds with the exocyclic amine of purine bases.
BPDE has been blamed for scrotum cancers (sooty warts) of
chimney sweeps in the 18th century England, for skin cancers
of fuel industry workers in the 19th century, and for lung can-
cers in cigarette smokers. NMR studies of BPDE-adduct DNA
suggest that the bulky and hydrophobic benzo[a]pyrene is of-
ten intercalated between base pairs and interferes with replica-
tion and transcription.
The crystal structure of Dpo4 complexed with a BPDE-dA
adduct, in which the modiﬁed base is paired with the 3 0-end
of the primer strand, revealed two alternative conformations
of the polyaromatic hydrocarbon, intercalated between base
pairs or placed in the major groove of DNA and exposed to
solvent (Fig. 4A) [40]. The intercalated conformation is ener-
getically favorable as the large hydrophobic surface of BP is
protected from the bulk solvent, but the intercalated BP sepa-
rates the 3 0-hydroxyl group of the primer strand from the a-
phosphate of the incoming nucleotide by 10 A˚ (Fig. 4A). When
the BP is displaced in the major groove, however, the 3 0 hydro-
xyl group and the a-phosphate are within reach of one anotherFig. 4. The crystal structure of Dpo4 complexed with BPDE-dA
adduct. (A) Two conformations of the BPDE-dA adduct are shown in
stick models superimposed with OMIT electron density maps. The
BPDE moiety is highlighted in hot pink (PDB: 1S0M). (B) When the
BPDE moiety is fully exposed to solvent in the major groove, the 3 0-
OH of the primer strand is juxtaposed to the a-phosphate of the dATP.
Dpo4 is shown in gray surface; DNA is shown in yellow sticks with
BPDE-dA adduct highlighted in red and the incoming dATP in
orange. The divalent cations are shown as cyan spheres.for the nucleotidyl transfer reaction (Fig. 3B). Addition of or-
ganic solvents (DMSO, isopropanol, ethanol, etc.) to the reac-
tion buﬀer, which reduces the dielectric constant and
presumably stabilizes the solvent-exposed BP conformation,
indeed increases the rate at which Dpo4 bypasses BPDE-
adducts [40].7. Concluding remarks
It is clear that Dpo4 accommodates a variety of modiﬁed
templates and achieves translesion synthesis in various ways.
Additional structural studies of Y-family polymerases will fur-
ther reveal unique features and substrate speciﬁcities of indi-
vidual members. The question of how a cell selects and
recruits a particular repair polymerase at a lesion-stalled repli-
cation fork is most intriguing. Ubiquitylation and sumoylation
of the replication processivity factor, PCNA, have been impli-
cated [41,42], but the mechanism of polymerase switching re-
mains the frontier and focus of future research.Acknowledgments: I thank Drs. D.J. Leahy and R. Craigie for proof-
reading the manuscript. The ﬁgures are made using PyMol and
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